Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Experimental Dermatology|November 9, 2005
Comparative genomic hybridization analysis of cutaneous large B-cell lymphomasSònia Giménez, Carlota Costa, Blanca Espinet, et al.BMC Cancer|May 16, 2016
Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancerLaura Bonanno, Carlota Costa, Margarita Majem, et al.Journal of the National Cancer Institute|August 25, 2011
mRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in advanced gastric cancerJia Wei, Carlota Costa, Yitao Ding, et al.Translational Lung Cancer Research|March 26, 2015
CK-coated magnetic-based beads as a tool to isolate circulating tumor cells (CTCs) in human tumorsClara Mayo, Francisco G Ortega, Ana Giménez-Capitán, et al.Journal of Translational Medicine|September 29, 2011
mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patientsMariacarmela Santarpia, Ignacio Magri, Maria Sanchez-Ronco, et al.Lung Cancer (Amsterdam, Netherlands)|May 28, 2011
Fifth Educational Symposium of the Spanish Lung Cancer Group: report on the Molecular Biology WorkshopIsabel Bover, Christian Rolfo, Eloisa Jantus-Lewintre, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2013
BRCA1, LMO4, and CtIP mRNA expression in erlotinib-treated non-small-cell lung cancer patients with EGFR mutationsNiki Karachaliou, Carlota Costa, Ana Gimenez-Capitan, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cellsMiguel A Molina-Vila, Jordi Bertran-Alamillo, Noemí Reguart, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2014
The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trialCarlota Costa, Miguel Angel Molina, Ana Drozdowskyj, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2011
Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutationsRafael Rosell, Miguel Angel Molina, Carlota Costa, et al.Pageof 4